Tohru Satoh
President/CEO
The startup develops high-intensity focused ultrasound therapy systems that provide precise tissue targeting and real-time imaging for cancer treatment. This technology enhances treatment accuracy and patient comfort while addressing the limitations of traditional invasive surgical methods.
Raised to date
$21.8MRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.



President/CEO
Traditional invasive surgical methods for cancer treatment can be limited by their lack of precision, potential for damage to surrounding healthy tissue, and longer recovery times for patients. These limitations can lead to increased complications and reduced quality of life for cancer patients.
The startup develops high-intensity focused ultrasound (HIFU) therapy systems that offer precise tissue targeting and real-time imaging capabilities for cancer treatment. This non-invasive technology allows clinicians to target and ablate cancerous tissue with greater accuracy, minimizing damage to surrounding healthy tissue. The real-time imaging provides enhanced visualization and control during the procedure, leading to improved treatment outcomes and patient comfort. By addressing the limitations of traditional surgical methods, the HIFU system offers a less invasive and more targeted approach to cancer treatment.
The primary target audience includes oncologists, radiologists, and hospitals specializing in cancer treatment, as well as patients seeking less invasive treatment options.